Enliven Therapeutics
ELVN
#5492
Rank
HK$8.16 B
Marketcap
HK$167.16
Share price
-2.36%
Change (1 day)
90.12%
Change (1 year)

EPS for Enliven Therapeutics (ELVN)

EPS in 2023 (TTM): -HK$12.04

According to Enliven Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$11.95. In 2021 the company made an earnings per share (EPS) of -HK$4.69 a decrease over its 2020 EPS that were of -HK$3.59.

EPS history for Enliven Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$12.04
2021-HK$4.6930.44%
2020-HK$3.59